3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Uterine Cervical Neoplasms
3
Vaginal Neoplasms
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neuroendocrine Tumors
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Accelerated Phase
1
Gallbladder Neoplasms
1
Blast Crisis
1
Interventions
Mycophenolic Acid
25
fludarabine phosphate
21
Whole-Body Irradiation
21
Cyclophosphamide
21
Cyclosporine
16
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
15
Busulfan
14
fludarabine
11
Cord Blood Stem Cell Transplantation
9
Methotrexate
8
Melphalan
8
Granulocyte Colony-Stimulating Factor
8
Cytarabine
8
Antilymphocyte Serum
8
Filgrastim
7
Thiotepa
6
Etoposide
6
sargramostim
4
merphos
4
Radiotherapy
4
Drug Therapy
4
Cyclosporins
4
Azacitidine
4
thymoglobulin
3
Vorinostat
3
Sirolimus
3
Lenalidomide
3
Idarubicin
3
tipifarnib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory, with Excess of Blasts
×
3-aminopyridine-2-carboxaldehyde thiosemicarbazone
×
Clear all
No trials found.